Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Dureja C, Rutherford JT, Pavel FB, Norseeda K, et al. In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy. Antimicrob Agents Chemother 2024;68:e0122223.
PMID: 38265216


Privacy Policy